Biotech Stock Picking for Charity - 2006 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2006

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kenhott who wrote (526)	11/20/2006 6:04:36 PM
From: Mike McFarland	of 592

It's been around for so long, and has been taken in much larger doses--makes sense, is very probably safe, certainly at these new doses. SILENOR(TM) is a low-dose (1 mg, 3 mg, 6 mg) oral tablet formulation of doxepin HCl that is patent protected for its use in insomnia. Doxepin has been prescribed for more than 35 years for the treatment of depression and anxiety at dosages typically ranging from 75 mg to 300 mg per day. At the currently prescribed high doses, doxepin is known to have a range of undesirable side effects, including anticholinergic effects. However, at the doses used in SILENOR(TM) in controlled clinical trials completed by Somaxon to date, these side effects have not been observed. medicalnewstoday.com I take something like 30 or 35mg, the side effects are one of the plusses for me, sleep more, and wake up to piss less often. I cannot imagine going back to Ambien or any of the others. Of course dose and effect that works for me probably would not be very palatable for most (heh, dry mouth too...)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next